Serum Life Science Europe GmbH
Dr. Gerald P. Parzmair is an accomplished professional in the life sciences field with extensive experience in leadership and research. Currently serving as Chief Operating Officer and Chief Scientific Officer at Serum Life Science Europe since July 2016, Dr. Parzmair has also held roles as Senior Project Manager and Clinical Project Manager. Additionally, Dr. Parzmair is set to take on the role of Chief Development Officer at Memo Therapeutics AG starting December 2022. Previous experiences include research positions at Helmholtz Centre for Infection Research and Medical University of Graz, along with a background in support for individuals with disabilities. Dr. Parzmair holds a Doctor rerum naturalium degree in Immunregulation from Otto-von-Guericke University Magdeburg, and Master and Bachelor of Science degrees in Genetics from Paris Lodron Universität Salzburg and Universität Salzburg, respectively.
This person is not in the org chart
This person is not in any teams
Serum Life Science Europe GmbH
Serum Life Science Europe GmbH (SLS Europe) – formerly Vakzine Projekt Management GmbH (VPM) – offers tailor-made consultancy and services supporting biopharmaceutical development in Europe and beyond. We offer exceptional knowledge in the development of biopharmaceutical candidates and a team that has vast experience in clinical and translational project management. This enables you to bring your development projects into clinical trials and market authorization faster, more cost-effectively and with a higher probability of success. Our company was established in 2002. Within the last two decades, we have successfully managed and have provided consultations on the development of promising biopharmaceutical candidates, ranging from small molecules, recombinant proteins to gene-modified live vaccines and ATMPs. You can find our customers in the pharmaceutical industry, academic research, start-ups, biotechnology companies, as well as private funding organizations. We have successfully guided their products from preclinical phases through clinical phases I-III and marketing authorization. Privacy policy for social media profiles: https://sls-eu.com/social-media-privacy-policy/